People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Labrys Biologics, Inc. | — | Pharmaceuticals | Series A | $14.6M | $451.8M | 2012 |
Robert P. Adelman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert P. Adelman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Wende Hutton | 1 | 16 |
| Corey Goodman | 1 | 13 |
| Michael F. Powell | 1 | 6 |
| Nina S. Kjellson | 1 | 4 |
| Steve P. James | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.